Clinical use of an analysis of oxidative stress and IL-6 as the promoters of diabetic polyneuropathy
- Emina Karahmet
(University of Tuzla, Tuzla, Faculty of Pharmacy, Bosnia and Herzegovina)
- Besim Prnjavorac (General Hospital, Tešanj, Tešanj, Bosnia and Herzegovina)
- Tamer Bego (Faculty of Pharmacy, Sarajevo, Department of Clinical Biochemistry, Bosnia and Herzegovina)
- Adaleta Softić (University of Tuzla, Tuzla, Department of Biochemistry, Bosnia and Herzegovina)
- Lejla Begić (University of Tuzla, Tuzla, Department of Biochemistry, Faculty of Pharmacy, Bosnia and Herzegovina)
- Edin Begić (General Hospital "Prim.dr. Abdulah Nakaš", Sarajevo, Department of Cardiology, Bosnia and Herzegovina)
- Esma Karahmet (Faculty of Pharmacy, Sarajevo, Department of Clinical Biochemistry, Bosnia and Herzegovina)
- Lejla Prnjavorac (General Hospital, Tešanj, Tešanj, Bosnia and Herzegovina)
- Irfan Prnjavorac (General Hospital, Tešanj, Tešanj, Bosnia and Herzegovina)
Abstract
Aim: To investigate interleukin 6 (IL-6) values depending on duration of diabetes mellitus (DM) and evaluate possible correlation with diabetic polyneuropathy.
Methods: The research study included 90 patients with DM divided into three groups (30 patients each) according to the duration of DM: group A - patients who had DM for less than 10 years, group B - duration of DM was 10 to 20 years, and group C - patients with DM over 20 years. Control group (K) included 30 healthy participants.
Results: IL-6 was significantly higher in the healthy control group, 180.318 pg/mL±94.18, than in group A, 47.23pg/ml±34.8, group B, 43.31pg/ml±33.17, and group C, 70.39 pg/ml±59.26 (p=0.0001). All groups had significantly different values of IL-6 between each other (p=0.0001). Level of IL-6 was in correlation with diabetic polyneuropathy in the group A (the youngest participants) (p=0.0001). In other groups there was no significant correlation between IL-6 and diabetic polyneuropathy.
Conclusion: The level of IL-6 was in correlation with neuropathy among younger patients. A higher level of IL-6 in the control group than in diabetic groups is a sign of stronger inflammatory response among younger and healthy people than in patients with DM.
Keywords: diabetes, interleukins, inflammation, neuropathy
How to Cite:
Karahmet, E., Prnjavorac, B., Bego, T., Softić, A., Begić, L., Begić, E., Karahmet, E., Prnjavorac, L. & Prnjavorac, I., (2020) “Clinical use of an analysis of oxidative stress and IL-6 as the promoters of diabetic polyneuropathy”, Medicinski glasnik 18(1), 12-17. doi: https://doi.org/10.17392/1279-21
Downloads:
Download PDF
View PDF
0 Views
0 Downloads